P-glycoprotein is a highly conserved membrane protein shown to be overexpressed in many multidrugresistant tumor cell lines. P-glycoprotein is encoded by a small gene family in mammalian cells. Class I and II isoforms cause multidrug resistance, whereas class m does not. In this report, we have characterized three P-glycoprotein-specific monoclonal antibodies (mAbs) by high-resolution epitope mapping with a series of hexapeptides. mAb C494 is gene specific, binding to a sequence present only in the class I isoform of hamster and human. The mAb C32 recognizes a sequence conserved in hamster class I and II isoforms but not in class III isoforms. In contrast, the mAb C219 recognizes a highly conserved amino acid sequence found in all P-glycoprotein isoforms characterized to date. These mAbs were used to reveal differential expression and specific localization of the three P-glycoprotein isoforms in hamster tissues by immunohistochemical staining and competition with epitope-specific peptides. Colonic epithelial cells expressed predominantly the class I isoform in a polarized manner, adrenal cortical cells expressed predominantly the class II isoform, whereas a small percentage of skeletal muscle fibers expressed the class III isoform of Pglycoprotein. These findings suggest that the P-glycoprotein isoforms have distinct physiological roles associated with specialized cell functions.
ABSTRACT
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The development of multidrug-resistant tumor cells during malignant progression may be a major factor contributing to nonresponse in chemotherapeutic treatment of cancer. The increased expression of the membrane P-glycoprotein (Pgp; Mr, 170,000) is the most consistent change seen in multidrugresistant cells in vitro, and gene transfer studies have shown this change to cause multidrug resistance (MDR) (1) (2) (3) . The role of Pgp as an energy-dependent efflux pump was proposed from its primary sequence and structural similarity to many membrane-associated transport proteins-most notably, the bacterial transport protein hemolysin B (4) (5) (6) . The presence of Pgp or its mRNA transcript has been demonstrated in a variety of human malignant tumors, and Pgp may play a role in limiting a patient's response to chemotherapy (7) (8) (9) (10) (11) . Pgp is also found in certain normal tissues, including large intestine, adrenal glands, kidney, liver, and brain (12) (13) (14) (15) (16) (17) (18) ; such localization has led to the speculation that this glycoprotein is involved in normal detoxification and transport of lipophilic molecules.
Recent data indicate that Pgp is encoded by a family of three genes in rodent and two genes in human (19) . A comparison of the amino acid sequences among the different gene family members, or isoforms, indicates a similar overall structure (20) . However, transfection studies that used fulllength cDNAs have suggested that only some Pgp isoforms confer a MDR phenotype on otherwise drug-sensitive cells (19, 21) . Thus, the class I and II isoforms have been directly implicated in drug resistance, whereas the function of the class III isoform is not known (19) . A study of the differential expression of Pgp isoforms in normal mouse tissues where gene-specific cDNA probes and Northern (RNA) blot analysis were used has been recently described (22) . However, localization of Pgp expression was not possible in that study.
Immunohistochemical staining of tissue for Pgp expression has the advantages of single cell localization and detection of polarized distribution. However, until now the question of differential gene expression could not be addressed with the available monoclonal antibodies (mAbs). In the present study, we report on the epitope mapping ofthree Pgp-specific mAbs to a resolution of a single amino acid. In addition, we demonstrate the differential expression of Pgp isoforms in hamster tissues by using these reagents and their epitopespecific peptides in a competitive immunohistochemical staining assay. (23) . The peptides were assembled on the pins in the Cto N-terminus direction by using 9-fluorenylmethyloxycarbonyl-protected amino acids (24) . Larger quantities of the characterized linear epitopes of mAbs C219, C494, and C32 were synthesized by classical solid-phase methods (25, 26 
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Immunohistochemical Staining. Frozen sections of normal Chinese hamster tissues were fixed in cold acetone (10 min at 40C) and then stained for Pgp by using an avidin-biotinperoxidase complex technique. The primary antibody (C219, C32, or C494) was used at 10 ,ug/ml in 1% bovine serum albumin/PBS. One hour before incubation of tissue sections with the primary antibody, the antibody solution was preincubated with a 100-fold molar excess of either the peptide encoding the antibody epitope or an irrelevant peptide. Competitive binding of the primary antibody to the peptide and to Pgp present in tissues proceeded for 1 hr at room temperature in a humidified chamber. The sections were washed with PBS and incubated sequentially with biotinylated horse anti-mouse antibody and with avidin-biotinperoxidase complex (Vector Laboratories), according to manufacturer's instructions. The binding of the antibody to tissues was detected by 5-min incubation with 3,3'-diaminobenzidine tetrahydrochloride (1 mg/ml; Sigma) and hydrogen peroxide (0.003%). Tissues were counterstained with hematoxylin, dehydrated, and mounted in Permount.
RESULTS AND DISCUSSION Epitope Mapping. Overlapping hexapeptides covering the entire 211-amino acid fragment from the C-terminal cytoplasmic domain of hamster pgpl [shown previously to contain all three mAb-binding sites (27) ] were synthesized on polypropylene pins (Fig. 1) . Each successive pin contained the last five residues of the preceding one and the following amino acid in the sequence. A library of -250 peptides, including all 206 hexapeptides to span this segment of the protein, was screened by ELISA with each mAb to determine its binding sequence. mAb C219 reacted more strongly with the two peptides 198 and 199 than with any other peptides tested. mAb C494 reacted with four successive peptides (peptides [17] [18] [19] [20] , giving a stronger signal than mAb C219. In contrast, mAb C32 binding to synthetic hexapeptides was substantially weaker. The strongest binding ofmAb C32 occurred over two peaks, peptides 119, 120 and 125-129. As detailed below, the weakness of these signals is attributed to the small size of the hexapeptide relative to the size of the mAb C32 epitope.
The results in Fig. 2 represent the relative intensities of the ELISA signals obtained for the binding of the three mAbs to the generated synthetic peptides. The movement of the 6-amino acid window defines the boundaries of the continuous epitopes and identifies some amino acids critical for binding. For example, mAb C219 bound strongly to the amino acid sequence [in single-letter code (28)] VQEALD with Val-506 and Asp-511 representing two critical amino acids required for antigen recognition. mAb C494 bound to four hexapeptides covering the amino acid sequence KP-NTLEGNV with Thr-323 and Glu-325 as the critical residues. Differences in the number of hexapeptides involved in antibody binding when using this assay are likely related to the size of the epitope recognized by a given antibody and the number of residues (distance) between the critical amino acids in a given epitope. mAb C32-binding domain covers a stretch of 13 amino acids (GDNSRVVSQDEIER), with four critical amino acids associated with its binding-Asp-427 and Val-431 from the first domain and Glu-436 and Glu-438 from the second. The weak signals seen for mAb C32 in Fig. 1 were due to the small size of the synthetic hexapeptides used to probe for its epitope. A comparable ELISA signal to that seen with mAb C494 was obtained with mAb C32 when the complete sequence of 13 amino acids (GDNSRVVSQ-DEIER) was synthesized on these pins (Inset of Fig. 1, mAb  C32 graph) . Extension of the peptide sequences for the mAb C219 and C494 epitopes, however, did not result in any increased signal.
The amino acid sequences of the antigenic peptides from Fig. 1 were located on the full structure of Pgp, as shown in Fig. 2 . mAb C219 binds to an amino acid sequence 6 residues away from the consensus sequence of the B site of the proposed ATP-binding domain. A homologous amino acid sequence for mAb C219 is also found in the N-terminal half of Pgp. The epitope recognized by mAb C494 is on the other side of the ATP-binding domain to that of mAb C219. mAb C32 binds to a region positioned between the A and B sites of the postulated ATP-binding domain. However, the Nterminal half of Pgp does not contain a homologous sequence for the mAb C494 or C32 epitope.
Identification of mAbs As Gene-Specific Probes. Fig. 3 lists the relative signals from the ELISA performed by using analogous peptide sequences from the different Pgp isoforms. The binding of mAb C219 to the peptide sequence VQAALD in the N-terminal half of rodent Pgp isoforms was stronger than that seen for the epitope sequence VQEALD in the C-terminal half, due to a single amino acid substitution (alanine substituted for Glu-508). The substitution of valine expected molecular mass was immunoprecipitated from an in vitro expression system using only the mAb C219. These results further corroborate those seen using the synthetic peptides (J. Endicott, E.G., and V.L., unpublished observation).
Results from the ELISA for binding of peptide analogs of the mAb C494 epitope indicated that substitution of a single critical amino acid (Thr-323) by tryptophan in class II hamster (pgp2) or lysine in class III hamster (pgp3) and human (mdr3) causes complete loss of antibody recognition. These findings confirm that mAb C494 is a specific immunological probe for the expression of human (mdrl) and hamster (pgpl) Pgp class I isoform (Fig. 3) . Because in vitro transfection studies have shown that human class I gene (mdrl) can confer MDR in a variety of cells (29) , positive staining with mAb C494 may be predicted in cells expressing the MDR phenotype in human tissues. Analogs for only part of the mAb C32-binding domain (SQDEIER) were synthesized for comparison between the different isoforms of Pgp because the remainder of the same antibody binding domain is conserved among the different members of Pgp gene families. The signals in Fig. 3 show the effect of a single critical amino acid substitution on binding of mAb C32 to this peptide (e.g., antibody is not bound when valine is substituted for Glu-438). Therefore, mAb C32 should bind most strongly to hamster class I and II products and much more weakly to the other Pgp isoforms. In agreement with the above conclusion, previous results have shown that hamster Pgp binds more strongly to mAb C32 than that of mouse and human using a Western (immunologic) blot technique (30) .
Immunohistochemical Staining. Serial sections of each tissue were incubated with each of the three mAbs, either with or without a peptide containing the respective epitope sequence. Specific staining by mAb against Pgp was defined as staining that could be completely abolished by competition with 100-fold molar excess of the epitope-containing peptide. This allowed positive identification of epitope-specific staining and contrasted with conventional immunohistochemical staining in which an "irrelevant" antibody is used as negative control.
Staining with all three antibodies, in which there was no competition among them, was frequently observed. Notably, The epitope-mapping studies predict that three distinct patterns of reactivity with the mAb panel would result from the expression of each of the three hamster Pgp isoforms ( Table 1) .
Staining of intestinal tissue sections with mAb C494 alone (Fig. 4A ) and in the presence of a peptide containing the mAb C494 epitope (Fig. 4B) mAbs C219 and C32 (data not shown). This staining pattern is consistent with the predominant expression of the class I Pgp isoform (see Table 1 ). (Table 1) .
Hamster skeletal muscles incubated with mAb C219 (Fig.  4E) showed staining of =5% of muscle fibers. However, the staining was completely abolished in the presence of peptide containing the mAb C219 epitope (Fig. 4F) 
